Oscar Health Inc (NYSE:OSCR) shares are trading higher Wednesday morning after a new SEC Form 4 showed CEO Mark Bertolini purchased 1 million Class A shares at $11.92 each in a private placement transaction, a roughly $11.92 million insider buy that can act as a confidence signal for investors.

CEO Stock Purchase Sends A Strong Confidence Signal

The filing also showed Bertolini had 5.73 million performance stock units vest, with 1,000,001 shares withheld to satisfy tax obligations, but the clean read-through for traders is the open purchase from the company itself.

When a CEO commits that much capital, the market often interprets it as a sign management believes the stock is undervalued or that the company’s outlook remains stronger than the market is pricing in.

Oscar’s ACA-Focused Platform Keeps Growth Story In View

That matters for Oscar because it is not just another generic insurance name. Oscar is a technology-focused health insurer built around a full-stack platform, with its business centered primarily on individual and family ACA plans, care-navigation tools and other tech-enabled insurance offerings, rather than being a pure-play Medicare Advantage insurer.

Oscar recently reported record membership of about 3.4 million, underscoring the scale of its consumer-facing insurance platform. The insider-buy filing may also be reinforcing a broader constructive backdrop for managed-care names after CMS finalized 2027 Medicare Advantage and Part D payment policies.

OSCR RSI Rebounds Toward Upper Neutral Range Without Hitting Overbought

OSCR’s RSI has mostly stayed in the neutral range (30–70) over the past six months, with repeated swings between the low-30s and mid-60s, indicating choppy but balanced momentum rather than a sustained trend.

Brief dips into oversold territory near 25 and occasional pushes toward the low-60s suggest short-term trading cycles, with the latest move showing RSI rising back toward the upper end of neutral.

OSCR Shares Climb Wednesday Morning

OSCR Price Action: Oscar Health shares were trading at $14.77, up 13.88% at the time of publication on Wednesday, according to Benzinga Pro data.

Image: Shutterstock